Literature DB >> 8625034

The relative survival rate.

D E Henson1, L A Ries.   

Abstract

Mesh：

Year:  1995        PMID： 8625034     DOI： 10.1002/1097-0142(19951115)76:10<1687::aid-cncr2820761002>3.0.co;2-i

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  38 in total

1.  Estimating potential savings in cancer deaths by eliminating regional and social class variation in cancer survival in the Nordic countries.

Authors:  P W Dickman; R W Gibberd; T Hakulinen
Journal:  J Epidemiol Community Health       Date:  1997-06       Impact factor: 3.710

2.  Conditional survival among cancer patients in the United States.

Authors:  Ray M Merrill; Bradley D Hunter
Journal:  Oncologist       Date:  2010-07-20

3.  Follicular lymphoma in Sweden: nationwide improved survival in the rituximab era, particularly in elderly women: a Swedish Lymphoma Registry study.

Authors:  H R Junlén; S Peterson; E Kimby; S Lockmer; O Lindén; H Nilsson-Ehle; M Erlanson; H Hagberg; A Rådlund; O Hagberg; B E Wahlin
Journal:  Leukemia       Date:  2014-08-25       Impact factor: 11.528

4.  Cancer patient survival improvement is correlated with the opening of a community cancer center: comparisons with intramural and extramural benchmarks.

Authors:  Robert O Dillman; Sherri D Chico
Journal:  J Oncol Pract       Date:  2005-09       Impact factor: 3.840

5.  Expected long-term survival of patients diagnosed with multiple myeloma in 2006-2010.

Authors:  Hermann Brenner; Adam Gondos; Dianne Pulte
Journal:  Haematologica       Date:  2009-01-14       Impact factor: 9.941

6.  Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study.

Authors:  Sigurdur Y Kristinsson; Magnus Björkholm; Therese M-L Andersson; Sandra Eloranta; Paul W Dickman; Lynn R Goldin; Cecilie Blimark; Ulf-Henrik Mellqvist; Anders Wahlin; Ingemar Turesson; Ola Landgren
Journal:  Haematologica       Date:  2009-07-16       Impact factor: 9.941

7.  Improved survival in adult patients with acute lymphoblastic leukemia in the Netherlands: a population-based study on treatment, trial participation and survival.

Authors:  A G Dinmohamed; A Szabó; M van der Mark; O Visser; P Sonneveld; J J Cornelissen; M Jongen-Lavrencic; A W Rijneveld
Journal:  Leukemia       Date:  2015-08-19       Impact factor: 11.528

8.  Medical advances and racial/ethnic disparities in cancer survival.

Authors:  Parisa Tehranifar; Alfred I Neugut; Jo C Phelan; Bruce G Link; Yuyan Liao; Manisha Desai; Mary Beth Terry
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-09-29       Impact factor: 4.254

9.  Age at cancer diagnosis, amenability to medical interventions, and racial/ethnic disparities in cancer mortality.

Authors:  Parisa Tehranifar; Abhishek Goyal; Jo C Phelan; Bruce G Link; Yuyan Liao; Xiaozhou Fan; Manisha Desai; Mary Beth Terry
Journal:  Cancer Causes Control       Date:  2016-03-12       Impact factor: 2.506

10.  Ovarian cancer survival population differences: a "high resolution study" comparing Philippine residents, and Filipino-Americans and Caucasians living in the US.

Authors:  Maria Theresa M Redaniel; Adriano Laudico; Maria Rica Mirasol-Lumague; Adam Gondos; Gemma Leonora Uy; Jean Ann Toral; Doris Benavides; Hermann Brenner
Journal:  BMC Cancer       Date:  2009-09-24       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.